Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

PSX:ABOT Income Statement

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	72,385	68,177	55,475	49,258	42,570	35,283
Revenue Growth (YoY)	19.78%	22.90%	12.62%	15.71%	20.65%	17.00%
Cost of Revenue	48,196	48,283	43,715	34,821	26,554	23,499
Gross Profit	24,189	19,894	11,760	14,436	16,015	11,784
Selling, General & Admin	11,255	10,362	8,989	7,835	7,232	5,516
Other Operating Expenses	1,242	862.48	303.19	590.58	777.55	602.55
Operating Expenses	12,498	11,225	9,292	8,425	8,009	6,119
Operating Income	11,691	8,669	2,468	6,011	8,006	5,666
Interest Expense	-36.84	-11.74	-22.18	-25.41	-54.48	-70.39
Interest & Investment Income	596.11	621.67	893.59	995.1	571.13	344.36
Currency Exchange Gain (Loss)	-241.6	-16.2	-1,341	-779.79	-240.34	-105.83
Other Non Operating Income (Expenses)	56.06	58.55	71.27	41.08	108.9	150.21
EBT Excluding Unusual Items	12,065	9,321	2,069	6,242	8,392	5,984
Gain (Loss) on Sale of Assets	105.03	31.14	20.26	-94.33	18.92	4.16
Asset Writedown	-225.04	-225.04	-	-	-	-
Other Unusual Items	-	-	500.05	-	-	255.46
Pretax Income	11,945	9,128	2,590	6,148	8,410	6,244
Income Tax Expense	5,308	3,893	2,328	3,143	2,443	1,708
Net Income	6,637	5,234	261.78	3,004	5,967	4,535
Net Income to Common	6,637	5,234	261.78	3,004	5,967	4,535
Net Income Growth	107.33%	1899.50%	-91.29%	-49.65%	31.57%	248.90%
Shares Outstanding (Basic)	98	98	98	98	98	98
Shares Outstanding (Diluted)	98	98	98	98	98	98
EPS (Basic)	67.80	53.46	2.67	30.69	60.95	46.33
EPS (Diluted)	67.80	53.46	2.67	30.69	60.95	46.33
EPS Growth	107.39%	1899.50%	-91.29%	-49.65%	31.57%	248.90%
Free Cash Flow	3,778	1,652	-3,137	212.23	5,768	6,768
Free Cash Flow Per Share	38.59	16.87	-32.04	2.17	58.92	69.13
Dividend Per Share	10.000	10.000	-	15.000	40.000	40.000
Dividend Growth	-	-	-	-62.50%	-	433.33%
Gross Margin	33.42%	29.18%	21.20%	29.31%	37.62%	33.40%
Operating Margin	16.15%	12.72%	4.45%	12.20%	18.81%	16.06%
Profit Margin	9.17%	7.68%	0.47%	6.10%	14.02%	12.85%
Free Cash Flow Margin	5.22%	2.42%	-5.65%	0.43%	13.55%	19.18%
EBITDA	13,425	10,366	3,966	7,368	9,119	6,649
EBITDA Margin	18.55%	15.20%	7.15%	14.96%	21.42%	18.84%
D&A For EBITDA	1,734	1,697	1,498	1,357	1,113	983.72
EBIT	11,691	8,669	2,468	6,011	8,006	5,666
EBIT Margin	16.15%	12.72%	4.45%	12.20%	18.81%	16.06%
Effective Tax Rate	44.44%	42.65%	89.89%	51.13%	29.05%	27.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.